Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 13, Art. 42 (pp. 524-537)    |    2012       

»

Stromal CLL microenvironment of lymph nodes

N.Y.Semenova, V.I.Rugal

Research Institute of Hematology and Blood Transfusion
Russia, St-Petersburg

Brief summary

Stromal lymphoid tissue microenvironment state estimation at lymphoid precursor’s malignant transformation is important in lymphoproliferative diseases progression mechanisms disclosure because today it is fixed that stromal cells of lymphoid organs including lymph nodes play great role in normal lymphopoiesis and immunogenesis. Taking into account this fact, analysis of lymph nodes nonparenchymal element structural features seems to be actual. The aim of review was to analyze literary data about lymph nodes stroma state in one of the most widespread lymphoproliferative diseases – CLL, with nodes \' lymphoid tissue involvement in the process.


Key words

chronic lymphatic leukemia, stroma of lymph nodes, microenvironment

Reference list

1. Zhang J., Li L. Stem Cell Niche: Microenvironment and Beyond // J Biol Chem. – 2008. – Vol. 283, № 15. – P. 9499 –9503.


2. Purton L.E., Scadden D.T. The hematopoietic stem cell niche // StemBook, ed. The Stem Cell Research Community. - 2008. – Vol. 15. – P. 1-14.


3. Yin T., Li L. The stem cell niches in bone // J Clin Invest. - 2006. - Vol. 116. – P. 1195–1201.


4. Scadden D.T. The stem cell niche in health and leukemic disease // Best Pract Res Clin Haematol. – 2007. - Vol. 20, № 1. – P. 19–27.


5. Rygal V.I., Semenova N.U., Bessmelcev S.S. Sostoyanie intramedylyarnoi stromi bolnih nehodjkinskimi limfomami s porajeniem kostnogo mozga // Vestnik gematologii. – 2011. - T. VII, №2. - S. 36-37.


6. Semenova N., Bessmeltsev S., Rugal V. Stromal microenvironment lymph nodes in CLL // Haematologica.17 Congress EHA Amsterdam. Abstract Book. – 2012. - Vol. 97, № S1. – R. 521.


7. Kiseleva M.V. Morfo-fynkcionalnoe sostoyanie stromi limfaticheskih yzlov pri nekotorih limfoproliferativnih zabolevaniyah. Dissertaciya. Sankt-Peterbyrg, 2001.


8. Tsuda H., Nishimura H., Sawada T., Takatsuki K. The roles of lymph node stromal cells in proliferation of lymphoid leukemia cells // Br.J.Cancer. – 1990. - Vol. 61. – R. 362-364.


9. Bonato M., Pittaluga S., Tierens A. et al. Lymph node histology in typical and atypical chronic lymphocytic leukemia // Am J Surg Pathol. – 1998. - Vol. 22, № 1. – R. 49-56.


10. Park C-S., Choi Y.S. How do follicular dendritic cells interact intimately with B cells in the germinal centre? // Immunology. – 2005. - Vol. 114. – R. 2–10.


11. Herishanu Y., Perez-Galan P., Liu D. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia // Blood. – 2011. - Vol. 117, № 2. – R. 563-574.


12. Caligaris-Cappio F. Role of the microenvironment in chronic lymphocytic leukaemia // Br J Haematol. – 2003. - Vol. 123. – R. 380-388.


13. Belyanin V.L., Ciplakov D.E. Diagnostika reaktivnih giperplazii limfaticheskih yzlov. - SPb-Kazan, 1999. – 328 s.


14. D.Rait, B.Eddis, E.Leong. Morfologicheskaya diagnostika patologii limfaticheskih yzlov. - M.: Med.lit., 2008. – S. 42-86.


15. Krivolapov U.A., Leenman E.E. Morfologicheskaya diagnostika limfom. - SPb.: Kosta., 2006. – S. 45-48.


16. Rosati S., Kluin P.M. Chronic lymphocytic leukaemia: a review of the immunoarchitecture // Curr Top Microbiol Immunol. – 2005. - Vol. 294. - 91-107.


17. Hallek M., Cheson B.D., Cotovsky D. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines // Blood. - 2008. - Vol. 111. – R. 544-546.


18. Rawstron A.C., Bennett F.L., O`Connor S.J. et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia // N Engl J Med. - 2008. - Vol. 359, № 6. – R. 575-583.


19. Chiorazzi N., Rai K.R., Ferrarini M. Chronic lymphocytic leukemia // N Engl J Med. – 2005. - Vol. 352. - R. 804-815.


20. Montillo M., Hamblin T., Hallek M. et al. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies // Haematologica. - 2005. - Vol. 90, № 3. – R. 391-399.


21. Cordone I., Matutes E., Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity // Leukemia. - 1992. - Vol. 6, № 9. – R. 902-906.


22. Sherstneva E.S., Isaeva N.V., Zagoskina T.P. i dr. Klinicheskoe znachenie vnytrikletochnogo IL-8 y bolnih V-kletochnim hronicheskim limfoleikozom // Vestnik gematologii. – 2007. - T 3, №2. - S. 49-50.


23. Leenman E.E., Myhina M.S. i dr. Mesto dendritnih kletok v mikrookryjenii pri limfome Hodjkina. - Sankt-Peterbyrg, 2010.


24. Asplund S.L., McKenna R.W., Howard M., Croft S.H. Immunophenotype does not correlate with lymph node gistology in chronic lymphocytic leukemia/small lymphocytic lymphoma // Am J of Surg Pathol. – 2002. - Vol. 26. – R. 624-629.


25. Bueso-Ramos C.E., Ferrajoli A., Medeiros L.J. et al. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells // Hematology. – 2004. - Vol. 9. – R. 279-286.


26. Tangye S.G., Raison R.L. Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2 // Immunol Cell Biol. – 1997. - Vol. 75. – R. 127-135.


27. Jonathan W. Friedberg. CLL microenvironment: macro important // Blood. – 2011. - Vol. 117, № 2. – R. 377-378.


28. Bäckman E., Bergh A-C., Lagerdahl I. et al. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro // Haematologica. – 2007. - Vol. 92, № 11. – R. 1495-1504.


29. Gromer S., Urig S., Becker K. The thioredoxin system: from science to clinic // Med Res Rev. – 2004. - Vol. 24. – R. 40-89.


30. Weistner A., Rosenwald A., Barry T.S. et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile // Blood. – 2003. - Vol. 101. – R. 4944-4951.


31. Amin S., Parker A., Manu J. Zap 70 in chronic lymphocytic leukemia // Int J Biochem Cell Biol. – 2008. – Vol. 40, № 9. – P. 1654-1658.


32. Saitoh M., Nishitoh H., Fujii M. et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase [ASK-1] // Embo J. – 1998. - Vol. 17. – R. 2596-2606.


33. Burke-Gaffney A., Callister M.E., Nakamura H. Thioredoxin: friend or foe in human disease? // Trends Pharmacol Sci. – 2005. - Vol. 26. – R. 398-404.


34. Ghia P., Circosta P., Scielzo C. et al. Differential effects on CLL cell survival exerted by different microenvironmental elements // Curr Top Microbiol Immunol. – 2005. – Vol. 294. - P. 135-145.


35. Semenova N.U. Immynnaya gistohimiya pri izychenii nishi gemopoeticheskih stvolovih kletok // Vestnik gematologii. – 2011. - T. VII, №1. - S.41.


36. Semenova N.U., Rygal V.I. Morfofynkcionalnie osobennosti stromi limfaticheskih yzlov pri HLL // Vestnik gematologii. – 2011. - T. VII, №4. - S.45-46.